Cell-mediated immune responses in calves with anaplasmosis.
Explore the source record for details and available documents.
SEARCH · Search PubMed
Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
A long-acting injectable (Terramycin/LA) forulated to contain 200 mg/ml of oxytetracycline was tested and compared to a commercially available oxytetracycline injectable (Emicina) containing 50 mg/ml in the treatments of experimentally induced Anaplasma marginale infection in Colombian cattle. Group 1, consisting of 10 infected calves, served as non-treated controls. Ten infected calves (Group 2) were treated with two doses of Emicina, each at 10 mg/kg, intramuscularly (IM), and another ten infected calves (Group 3) were treated once IM, with 20 mg/kg of Terramycin/LA. All treatments were given during the acute phase of infection after A. marginale parasitemia was demonstrated and when the packed cell volume (PCV) had decreased to 60-64% of normal value. Two treatments with Emicina and one with Terramycin/LA were both effective in moderating the course of A. marginale infection and in preventing serious clinical signs of disease under laboratory conditions.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.